Cargando…

Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases

Inflammatory diseases have become increasingly prevalent with industrialization. To address this, numerous anti-inflammatory agents and molecular targets have been considered in clinical trials. Among molecular targets, protease-activated receptors (PARs) are abundantly recognized for their roles in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heuberger, Dorothea M., Schuepbach, Reto A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440139/ https://www.ncbi.nlm.nih.gov/pubmed/30976204 http://dx.doi.org/10.1186/s12959-019-0194-8

Ejemplares similares

Correction to: protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
por: Heuberger, Dorothea M., et al.
Publicado: (2019)

Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity
por: Price, Rachel, et al.
Publicado: (2021)

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets
por: French, Shauna L., et al.
Publicado: (2016)

Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
por: Das, Mitali, et al.
Publicado: (2022)

Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation
por: Saban, Ricardo, et al.
Publicado: (2007)

Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2015)

Protease-Activated Receptor (PAR)2, but Not PAR1, Is Involved in Collateral Formation and Anti-Inflammatory Monocyte Polarization in a Mouse Hind Limb Ischemia Model
por: van den Hengel, Lisa G., et al.
Publicado: (2013)

Streptococcal SpeB Cleaved PAR-1 Suppresses ERK Phosphorylation and Blunts Thrombin-Induced Platelet Aggregation
por: Ender, Miriam, et al.
Publicado: (2013)

Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
por: Han, Xu, et al.
Publicado: (2020)

Chemical Tools to Image the Activity of PAR-Cleaving Proteases
por: Lee, Irene Y., et al.
Publicado: (2023)

Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis
por: Huang, Xiaojian, et al.
Publicado: (2019)

Electrospun tube reduces adhesion in rabbit Achilles tendon 12 weeks post-surgery without PAR-2 overexpression
por: Bürgisser, Gabriella Meier, et al.
Publicado: (2021)

Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets
por: Arachiche, Amal, et al.
Publicado: (2013)

Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
por: Liu, Xuan, et al.
Publicado: (2017)

Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
por: Rwibasira Rudinga, Gamariel, et al.
Publicado: (2018)

Predictive value of protease‐activated receptor‐2 (PAR(2)) in cervical cancer metastasis
por: He, Shengnan, et al.
Publicado: (2020)

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
por: Medipally, Ajay, et al.
Publicado: (2022)

Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics
por: Tourdot, Benjamin E., et al.
Publicado: (2018)

GB83, an Agonist of PAR2 with a Unique Mechanism of Action Distinct from Trypsin and PAR2-AP
por: Heo, Yunkyung, et al.
Publicado: (2022)

Correction: Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets
por: Arachiche, Amal, et al.
Publicado: (2013)

Developmental Role of Zebrafish Protease-Activated Receptor 1 (PAR1) in the Cardio-Vascular System
por: Ellertsdottir, Elin, et al.
Publicado: (2012)

Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition
por: Meah, Mohammed N., et al.
Publicado: (2020)

Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer
por: Lin, Cong, et al.
Publicado: (2017)

Robust ParB Binding to Half-parS Sites in Pseudomonas aeruginosa—A Mechanism for Retaining ParB on the Nucleoid?
por: Kawalek, Adam, et al.
Publicado: (2023)

CTP and parS coordinate ParB partition complex dynamics and ParA-ATPase activation for ParABS-mediated DNA partitioning
por: Taylor, James A, et al.
Publicado: (2021)

The ParB-parS Chromosome Segregation System Modulates Competence Development in Streptococcus pneumoniae
por: Attaiech, Laetitia, et al.
Publicado: (2015)

suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022)

Triggering NETosis via protease-activated receptor (PAR)-2 signaling as a mechanism of hijacking neutrophils function for pathogen benefits
por: Bryzek, Danuta, et al.
Publicado: (2019)

Attenuated Vasodilator Effectiveness of Protease-Activated Receptor 2 Agonist in Heterozygous par2 Knockout Mice
por: Hennessey, John C., et al.
Publicado: (2013)

Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma
por: Tas, Faruk, et al.
Publicado: (2016)

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
por: Friebel, Julian, et al.
Publicado: (2021)

Analysis of ParAB dynamics in mycobacteria shows active movement of ParB and differential inheritance of ParA
por: Uhía, Iria, et al.
Publicado: (2018)

Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells
por: Suen, Jacky Y., et al.
Publicado: (2010)

Novel Role for Proteinase-activated Receptor 2 (PAR(2)) in Membrane Trafficking of Proteinase-activated Receptor 4 (PAR(4))
por: Cunningham, Margaret R., et al.
Publicado: (2012)

The uPAR System as a Potential Therapeutic Target in the Diseased Eye
por: Cammalleri, Maurizio, et al.
Publicado: (2019)

Platelet Specific Promoters Are Insufficient to Express Protease Activated Receptor 1 (PAR1) Transgene in Mouse Platelets
por: Arachiche, Amal, et al.
Publicado: (2014)

Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy
por: Ocasio-Rivera, Marinel, et al.
Publicado: (2020)

Long-term platelet priming after glycoprotein VI stimulation in comparison to Protease-Activating Receptor (PAR) stimulation
por: Zou, Jinmi, et al.
Publicado: (2021)

Intrinsic Expression of Coagulation Factors and Protease Activated Receptor 1 (PAR1) in Photoreceptors and Inner Retinal Layers
por: Goldberg, Zehavit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2v64ct63mgtbrhfsc6o8l175qk